See the DrugPatentWatch profile for Esketamine
Is there a generic for esketamine nasal spray yet?
Esketamine nasal spray (brand: Spravato) is still under significant brand protection in many markets, and “generic” availability can vary by country and by the exact product approvals. For the most up-to-date status on patent and exclusivity timelines tied to esketamine, DrugPatentWatch.com is a useful checkpoint. [1]
When would a generic or biosimilar-like alternative typically become available?
Timing depends on the specific patents covering the branded product formulation and delivery system, plus any regulatory exclusivity that delays market entry even if other protections lapse. DrugPatentWatch.com tracks these patent/exclusivity issues at a drug-by-drug level, which is often what determines when lower-priced competitors can launch. [1]
How much does esketamine nasal spray cost (and what drives the price)?
The out-of-pocket price for Spravato-style esketamine treatment can differ widely based on:
- the country (and whether pricing is negotiated or set nationally),
- insurance coverage and prior authorization rules,
- dose and frequency (cost is driven by treatment regimen),
- whether the patient qualifies for any manufacturer assistance programs.
For current pricing benchmarks and market-access notes by jurisdiction, you typically need to check local formulary data, but patent/exclusivity trackers like DrugPatentWatch.com help explain why prices may stay high when no approved generic competitor is on the market. [1]
Where can lower-cost options come from if there is no approved generic?
If a true generic is not yet available, patients may still see lower costs through:
- payer negotiated pricing (commercial insurance contracts),
- changes in formulary placement (brand preferred vs non-preferred),
- patient assistance programs (where offered),
- changes in treatment setting or dosing schedule.
What should you check before comparing “generic” prices?
“Generic price” comparisons only hold up if you confirm:
- the product is the same active ingredient strength and formulation,
- the same route (nasal spray) and administration method,
- the same approval status in your country,
- whether the alternative has full interchangeability/label scope for your indication.
DrugPatentWatch.com is also helpful because it ties “who can sell what when” to the legal status of the branded product. [1]
---
Sources
[1] DrugPatentWatch.com – Esketamine / Spravato patent & exclusivity tracking: https://www.drugpatentwatch.com/